John Maraganore, Chief Executive Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 69,530 shares at $144.33 ($10.0M) on 2020-05-20, disclosed to the SEC on 2020-05-22.
Open-market sale of $10.0M ALNY by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $142.51 | 13,437 | $1.9M | 19.2% |
| 2 | $142.51 | 13,437 | $1.9M | 19.2% |
| 3 | $143.46 | 16,315 | $2.3M | 23.5% |
| 4 | $143.46 | 16,315 | $2.3M | 23.5% |
| 5 | $144.33 | 5,013 | $724K | 7.3% |
| 6 | $144.33 | 5,013 |
| $724K |
| 7.3% |
| Total | $143.22 avg | 69,530 | $10.0M | 100% |
| Filing → |
| ALNY | SELL | 2021-05-17 | $8.9M | — | Filing → |
| ALNY | SELL | 2021-02-26 | $9.4M | — | Filing → |
| ALNY | SELL | 2020-11-20 | $8.6M | — | Filing → |